Melanoma is an aggressive and potentially fatal form of skin cancer that accounts for the majority (76.9%) of the 13,000 skin cancer-related deaths in the United States each year, even though it accounts for less than 2% of total skin-related cancers.2,5
MRV Research
MITF gene variant associated with increased melanoma risk, high nevi count
A rare functional variant in the MITF gene was associated with increased melanoma risk, especially in patients with multiple primary melanoma, and high nevi count, according to study results recently published in JAMA Dermatology.
Circulating melanoma cells predict relapse in stage III disease
Circulating melanoma cells at baseline or at 6-month follow-up served as an indicator for relapse among patients with stage III melanoma, according to results of a prospective study.
Melanoma Meets Microbiome
Two groundbreaking studies implicate specific bacterial species in regulating gut immunity and response to immunotherapy in physically distant tumors — an entirely new angle in cancer therapy.